Skip to main content
The Evidence Base has featured a ‘deep dive’ on the topic presented by Tijana Ignjatovic, Executive Director, and Kuldeep Singh, Executive Vice President, Genesis Research Group at ISPOR 2024: Understanding payer perceptions of health inequalities in health technology assessment and reimbursement decision-making.
_

Disparities in health outcomes and access to health care among different population groups are becoming increasingly important to be considered in health technology assessment (HTA) and reimbursement decision-making. To ensure that health inequalities are appropriately and systematically considered by all stakeholders, there is a need for a clear framework, better methods to measure inequality, and a shared understanding of how these factors should be considered alongside clinical outcomes.

In the ISPOR 2024 session titled, “Payer Perceptions of Health Inequalities in Reimbursement Decision Making: Implications for the Pharmaceutical Industry,” Kuldeep Singh and Tijana Ignjatovic of Genesis Research Group delved into this complex landscape. They shared results from a qualitative payer survey on perceptions of health equity and its role in decision-making, providing valuable insights into current stakeholder views on this critical issue.

Read more at The Evidence Base
_

The survey was carried out using our RPR stakeholder engagement solution. If you’d like to learn more about this, please get in touch via this form or email solutions@genesisrg.com.

 

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US